DE   EN   ES   FR   IT   PT


Medulak-WM

Препарат Медулак-WM. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания


Producer: "World Medicine" Great Britain ("UORLD MEDITSIN") Great Britain

Release form: Liquid dosage forms. Solution oral.

Indications to use:


General characteristics. Structure:

 Active agent: lactulose of 667 mg (33,35% of daily requirement).




Pharmacological properties:

Medulak - WM contains lactulose which is to synthetic derivatives of lactose. Lactulose does not break up in a stomach and in a small intestine due to the lack of the corresponding enzymes and is practically not soaked up. Getting into intestines, stimulates a peristaltics, improves absorption of phosphates and salts of calcium, increases diffusion of ammonia from blood in intestines and promotes its allocation from an organism.

In a large intestine of a lakguloz under the influence of an indestinal flora it is split on low-molecular organic acids - generally lactic acid both partially ant and acetic acids. At the same time osmotic pressure increases and pH in a gleam of a large intestine decreases, the volume of fecal masses increases that stimulates a peristaltics of a large intestine and normalizes a consistence of fecal masses. It promotes elimination of a lock and recovery of a physiological rhythm of bowel emptying.

Removal of the connected ions of ammonium is carried out at development of laxative effect. The laxative effect is shown in 24-48 hours after reception. Besides, the lakguloza removes bile acids with a stake, the content of cholesterol in blood and bile as a result decreases.

Lakguloza stimulates growth bifido-and the lactobacilli of a large intestine who are emitted at their reproduction organic acids promote reduction of pH of intestines and oppression of growth of pathogenic microorganisms (in particular salmonellas).

Does not reduce absorption of vitamins and minerals. Does not cause accustoming (there is no withdrawal).


Indications to use:

It is recommended as dietary supplement to food as an additional source of lactulose.


Route of administration and doses:

For intake.
Duration of reception and dose are established individually.
Before use it is recommended to consult with the doctor.


Features of use:

There are no data.


Side effects:

There are no data.


Interaction with other medicines:

Are not revealed.


Contraindications:

- hypersensitivity to product components;
- galactosemia;
- lactose intolerance, galactoses or fructose;
- impassability of intestines.


Overdose:

Data on overdose are not provided.


Storage conditions:

To store at a temperature not above 25 °C. To store in the place, unavailable to children! Not to freeze. After opening of a bottle to use within 28 days.


Issue conditions:

Without recipe


Packaging:

Solution for intake in a glass bottle of yellow color on 250 ml with a plastic cover.
1 bottle with a measured glass in a cardboard box.



Similar drugs

Препарат Лактофильтрум. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

Laktofiltrum

The enterosorbent regulating balance of intestinal microflora.



Препарат Дюфалак. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

Dyufalak

Purgative.



Препарат Порталак. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

Portalak

Purgative.



Препарат Гудлак . "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

Gudlak

Purgative.



Препарат Дюфалак. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

Dyufalak

Purgative.



Препарат Нормазе. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

To Normaza

Purgative.



Препарат Лаксарин. "World Medicine" Great Britain («УОРЛД МЕДИЦИН») Великобритания

Laksarin

Osmotic purgative, Lactulose.





  • Сайт детского здоровья